Back to substances
Deutsch|English
Translated automatically – community improvements welcome.
Memantine
Memantine is an NMDA receptor antagonist primarily used in the treatment of Alzheimer's dementia. It modulates glutamatergic neurotransmission and can exert neuroprotective effects. The substance shows a low risk of dependence and side effects compared to other dissociatives.
NMDA-Antagonist
Mechanism of Action
- NMDA receptor antagonism
Names / Identifiers
IUPAC: Memantine
memantine
19982-08-2
3,5-dimethyladamantan-1-amine
1-Amino-3,5-dimethyladamantane
Memantina
3,5-Dimethyl-1-adamantanamine
1,3-Dimethyl-5-adamantanamine
Memantinum
3,5-Dimethyl-1-aminoadamantane
nemdatine
Effects
neuroprotektiv
kognitive Verbesserung
Stimmungsaufhellung
Schmerzlinderung
Sedierung
Effects described from scientific sources. Individual experiences vary.
Dosage
Safety NoteIndividual variation, start at a low dose, no medical advice.
Individual sensitivity varies. Not a dosage recommendation.
Duration
Peak3-7 hours
NotesEffects may vary depending on individual sensitivity.
Onset1-4 hours
Total24 hours
After EffectsVariable, often mild
Risks & Warnings
Warnings
- Severe renal insufficiency
- Allergy to Memantine
Known Risks
- low
- Geringes Risiko für Abhängigkeit und Nebenwirkungen im Vergleich zu anderen Substanzen.
Safer Use
- Start at a low dose
- Regular medical check-ups
Harm reduction tips do not replace medical advice.
Known Interactions
- Alcohol
- Benzodiazepines
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
ATVerschreibungspflichtig
CHVerschreibungspflichtig
DEVerschreibungspflichtig
USVerschreibungspflichtig
NotesMemantine ist in vielen Ländern als Medikament zur Behandlung von Alzheimer zugelassen.
Not legal advice. Status may change.
Entdecken
Ähnliche Substanzen
Basierend auf Substanzklasse, Rezeptoren, Wirkmechanismen und Wirkprofil.